REPORTS

Let’s Pullulate and Expand Your Business

Healthcare CMO Market - Global Professional Analysis and Forecast to 2026

Mar 09, 2020  |  181 PAGES  |  REPORT CODE: CMM270941
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Healthcare CMO market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.0% during the forecast period.

This report presents the market size and development trends by detailing the Healthcare CMO market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Healthcare CMO market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Healthcare CMO industry and will help you to build a panoramic view of the industrial development.

Healthcare CMO Market, By Type:

  • Pharmaceutical CMOs

  • Medical Device CMOs

Healthcare CMO Market, By Application:

  • Medical

  • Healthcare

Some of the leading players are as follows:

  • Piramal Healthcare

  • Boehringer Ingelheim GmbH

  • Aurobindo Pharma Limited

  • Catalent Pharma Solution

  • DSM

  • Sanofi

  • Recipharm

  • Fareva

  • Lonza Group

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Healthcare CMO Market: Technology Type Analysis

  • 4.1 Healthcare CMO Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Healthcare CMO Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Pharmaceutical CMOs

    • 4.3.2 Medical Device CMOs

5 Healthcare CMO Market: Product Analysis

  • 5.1 Healthcare CMO Product Market Share Analysis, 2018 & 2026

  • 5.2 Healthcare CMO Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Healthcare CMO Market: Application Analysis

  • 6.1 Healthcare CMO Application Market Share Analysis, 2018 & 2026

  • 6.2 Healthcare CMO Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Medical

    • 6.3.2 Healthcare

7 Healthcare CMO Market: Regional Analysis

  • 7.1 Healthcare CMO Regional Market Share Analysis, 2018 & 2026

  • 7.2 Healthcare CMO Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Piramal Healthcare

    • 9.1.1 Piramal Healthcare Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Boehringer Ingelheim GmbH

    • 9.2.1 Boehringer Ingelheim GmbH Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Aurobindo Pharma Limited

    • 9.3.1 Aurobindo Pharma Limited Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Catalent Pharma Solution

    • 9.4.1 Catalent Pharma Solution Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 DSM

    • 9.5.1 DSM Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Sanofi

    • 9.6.1 Sanofi Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Recipharm

    • 9.7.1 Recipharm Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Fareva

    • 9.8.1 Fareva Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Lonza Group

    • 9.9.1 Lonza Group Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

 

The List of Tables and Figures (Totals 99 Figures and 161 Tables)

  • Figure Pharmaceutical CMOs Healthcare CMO market, 2015 - 2026 (USD Million)

  • Figure Medical Device CMOs Healthcare CMO market, 2015 - 2026 (USD Million)

  • Figure Medical market, 2015 - 2026 (USD Million)

  • Figure Healthcare market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Healthcare CMO market, by country, 2015 - 2026 (USD Million)

  • Table North America Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table North America Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table North America Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Canada Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Canada Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Europe Healthcare CMO market, by country, 2015 - 2026 (USD Million)

  • Table Europe Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Europe Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Europe Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Germany Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Germany Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table France Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table France Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Italy Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Italy Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Spain Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Spain Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Healthcare CMO market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table China Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table China Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Japan Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Japan Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table India Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table India Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Healthcare CMO market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table MEA Healthcare CMO market, by country, 2015 - 2026 (USD Million)

  • Table MEA Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table MEA Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table MEA Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Healthcare CMO market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Healthcare CMO market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Healthcare CMO market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Piramal Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aurobindo Pharma Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Catalent Pharma Solution Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DSM Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Recipharm Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fareva Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lonza Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top